Oaktop Capital Management Ii, L.P.
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), Oaktop Capital Management Ii, L.P. reported 15 stock positions worth $916.3 million. Its top holding was KLA (KLAC) at 33.1% of the portfolio, followed by Lam Research (LRCX, 24.0%) and Analog Devices (ADI, 11.7%). Compared with Q2 2024, it sold out of 1, added to 2 and reduced 2. The biggest buy was Aspen Aerogels (ASPN, shares +6%) and the biggest sale Bristol-Myers Squibb (BMY, shares −29%).
- Most Recent 13F
- Q2 2026
- Location
- Chatham, NJ
- CIK
- 0001550660
- Portfolio Value
- $916.3M (Q3 2024)
- SEC Filing
- 0001172661-24-004598 ↗ filed Nov 13, 2024
Holdings Value
Holdings 15 stocks · $916.3M
| KLAC KLA Corp. | 33.09% | 391,581 | $303.2M | Reduce -0.3% |
| LRCX Lam Research Corp. | 23.97% | 269,146 | $219.6M | No change |
| ADI Analog Devices Inc. | 11.71% | 466,196 | $107.3M | No change |
| ASPN Aspen Aerogels Inc. | 10.70% | 3,540,525 | $98.0M | Add +6.0% |
| AVGO Broadcom Inc. | 6.83% | 362,760 | $62.6M | No change |
| PRGS Progress Software Corp. | 3.74% | 508,608 | $34.3M | No change |
| BMY Bristol-Myers Squibb Co. | 2.71% | 479,991 | $24.8M | Reduce -29.4% |
| DELL Dell Technologies -C | 1.69% | 130,619 | $15.5M | No change |
| CEVA Ceva Inc. | 1.66% | 631,377 | $15.2M | No change |
| EGAN Egain Corp. | 1.49% | 2,671,843 | $13.6M | No change |
| GRMN Garmin Ltd. | 0.92% | 48,000 | $8.4M | No change |
| PINS Pinterest Inc. Class A | 0.88% | 250,000 | $8.1M | Add +150.0% |
| PRTS Carparts.com Inc. | 0.37% | 3,725,185 | $3.4M | No change |
| PETS Petmed Express Inc. | 0.17% | 435,844 | $1.6M | No change |
| INTC Intel Corp. | 0.06% | 23,010 | $540K | No change |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $2.4B | KLAC, LRCX, ADI, AVGO, DELL |
| Q1 2026 | 14 | $1.3B | LRCX, KLAC, ADI, AVGO, BMY |
| Q4 2025 | 13 | $1.2B | LRCX, KLAC, ADI, AVGO, EGAN |
| Q3 2025 | 15 | $1.1B | LRCX, KLAC, AVGO, ADI, ASPN |
| Q2 2025 | 15 | $929.6M | KLAC, LRCX, ADI, AVGO, PRGS |
| Q1 2025 | 15 | $750.8M | KLAC, LRCX, ADI, AVGO, BMY |
| Q4 2024 | 15 | $800.8M | KLAC, LRCX, ADI, AVGO, ASPN |
| Q3 2024 | 15 | $916.3M | KLAC, LRCX, ADI, ASPN, AVGO |
| Q2 2024 | 16 | $976.5M | KLAC, LRCX, ADI, ASPN, AVGO |
| Q1 2024 | 15 | $865.4M | KLAC, LRCX, ADI, ASPN, AVGO |